Flow cytometric differential of leukocyte populations in normal bone marrow: Influence of peripheral blood contamination

Cytometry Part B - Clinical Cytometry

Volumn 76, Issue 1, 2009, Pages 18-26

  Brooimans, R A ^a   Kraan, J ^a   van Putten, W ^a   Cornelissen, J J ^a   Lowenberg B ^a   Gratama, J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Blood admixture; Bone marrow; Flow cytometry; Reference values

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CD34 SELECTION; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE; MALE; MONOCYTE; PRIORITY JOURNAL; REFERENCE VALUE;

ANTIGENS, CD; BONE MARROW CELLS; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTES; MONOCYTES; REFERENCE VALUES;

EID: 62349103631     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20439     Document Type: Article

References (35)

1. Terstappen LWMM, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multidimensional flow cytometry. Anal Cell Pathol 1990;2:229-240.
2. van Lochem EG, van der Velden VHJ, Wind HK, te Marvelde JG, Westerdaal NAC, van Dongen JM. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age-related changes and disease-induced shifts. Cytometry Part B Clin Cytom 2004;60B:1-13.
3. Weir EG, Borowitz MJ. Flow cytometry in the diagnosis of acute leukemia. Semin Hematol 2001;38:124-138.
4. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987;70:1316-1324.
5. Terstappen LW, Safford M, Loken MR. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia 1990;4: 657-663.
6. Loken MR, Shah VO, Hollander Z, Civin CI. Flow cytometric analysis of normal B lymphoid development. Pathol Immunopathol Res 1988;7:357-370.
7. Terstappen LW, Safford M, Unterhalt M, Konemann S, Zurlutter K, Piechotka K, Drescher M, Aul C, Buchner T, Hiddemann W. Flow cytometric characterization of acute myeloid leukemia. IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells. Leukemia 1992;6:993-1000.
8. Ogata K, Satoh C, Hyodo H, Tamura H, Dan K, Yoshida Y. Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes. Leuk Res 2004;28:1171-1175.
9. Foon KA, Todd RF, III. Immunologic classification of leukemia and lymphoma. Blood 1986;68:1-31.
10. Abrahamsen JF, Lundjohansen F, Laerum OD, Schem BC, Sletvold O, Smaaland R. Flow cytometric assessment of peripheral-blood contamination and proliferative activity of human bone-marrow cell-populations. Cytometry 1995;19:77-85.
11. Loken MR, van de LA, Ogata K, Orfao A, Wells DA. Flow cytometry in myelodysplastic syndromes: Report from a working conference. Leuk Res 2008;32:5-17.
12. Smock KJ, Perkins SL, Bahler DW. Quantitation of plasma cells in bone marrow aspirates by flow cytometric analysis compared with morphologic assessment. Arch Pathol Lab Med 2007;131:951-955.
13. Orfao A, Ortuno F, de Santiago M, Lopez A, San Miguel J. Immuno-phenotyping of acute leukemias and myelodysplastic syndromes. Cytometry Part A 2004;58A:62-71.
14. Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A. Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry Part B Clin Cytom 2006;70B:39-44.
15. Holdrinet RS, von Egmond J, Wessels JM, Haanen C. A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp Hematol 1980;8:103-107.
16. Keeney M, Brown W, Gratama J, Papa S, Lanza F, Sutherland DR. Immunophenotypic characterization of CD34(pos) cells. J Biol Regul Homeost Agent 2003;17:254-260.
17. Boccuni P, LoPardo C, Alfinito F, Vacca C, Rotoli B, DelVecchio L. CD66 family expression during myeloid maturation. Tissue Antig 1996;48:MC302.
18. Bonde J, Meyer K, Broe MK, Hokland M, Turley H, Hokland P. Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13. CD14 and CD66 monoclonal antibodies. Br J Haematol 1996;92:269-279.
19. Kraan J, Gratama JW, Keeney M, D'hautcourt JL. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. J Biol Regul Homeost Agent 2003;17:223-233.
20. Vial JP, Durrieu F, Briais A, Dumain P, Bascans E, Belloc F, Reiffers J, Bernard P, Lacombe F. Flow cytometry CD45 gating proposed as a new standard for immunophenotyping of acute myeloid leukemia (AML). Blood 1997; 90:3745.
21. Stelzer GT, Shults KE, Loken MR. Cd45 gating for routine flow cytometric analysis of human bone-marrow specimens. Ann NY Acad Sci 1993;677:265-280.
22. Borowitz MJ, Bray R, Gascoyne R, Melnick S, Parker JW, Picker L, Stetler-Stevenson M. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation. Cytometry 1997;30: 236-244.
23. Bentley SA, Taylor MA, Killian DE, Schoultz SB, McLannan L, Bishop CA, Shea TC, Brecher ME. Correction of bone marrow nucleated cell counts for the presence of fat particles. Am J Clin Pathol 1995;104:60-64.
24. Sakamoto C, Yamane T, Ohta K, Hino M, Tsuda I, Tatsumi N. Automated enumeration of cellular composition in bone marrow aspirate with the CELL-DYN 4000 automated hematology analyzer. Acta Haematol 1999;101:130-134.
25. Faucher JL, Lacronique-Gazaille C, Frebet E, Trimoreau F, Donnard M, Bordessoule D, Lacombe F, Feuillard J. "6 markers/5 colors" extended white blood cell differential by flow cytometry. Cytometry Part A 2007;71A:934-944.
26. Bjornsson S, Wahlstrom S, Norstrom E, Bernevi I, O'Neill U, Johansson E, Runstrom H, Simonsson P. Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer. Cytometry Part B Clin Cytom 2008;74B:91-103.
27. Wells DA, Sale GE, Shulman HM, Myerson D, Bryant EM, Gooley T, Loken MR. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol 1998; 110:84-94.
28. de Witte T, Holdrinet R, Raymakers R, Wessels J, Haanen C. Influence of peripheral blood admixture on the number of hematopoietic progenitor cells (CFU-GM and BFU-E) in human bone marrow aspirates. Acta Haematol 1985;74:70-74.
29. Abrahamsen JF, Smaaland R, Skjaerven R, Laerum OD. Flow cytometric measurement of DNA S-phase in human bone marrow cells: Correcting for peripheral blood contamination. Eur J Haematol 1996; 56:138-147.
30. Bordessoule D, Jones M, Gatter KC, Mason DY. Immunohistological patterns of myeloid antigens: Tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. Br J Haematol 1993; 83:370-383.
31. Fujimoto H, Sakata T, Hamaguchi Y, Shiga S, Tohyama K, Ichiyama S, Wang FS, Houwen B. Flow cytometric method for enumeration and classification of reactive immature granulocyte populations. Cytometry 2000;42:371-378.
32. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102:394-403.
33. Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98:979-987.
34. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-2088.
35. Szczepanski T, van der Velden VH, van Dongen JJ. Flow-cytometric immunophenotyping of normal and malignant lymphocytes. Clin Chem Lab Med 2006;44:775-796.